Free tool
Stocks far below their 52-week high
We cover 5 companies trading at least 50% below their own 52-week high. The median market value in the group is $279.10M. Across the group, the median move over the past trading day is +2.85%. Price change over the past year runs from −57.8% to +429.8% across the middle 80 percent of the group, with a median of −33.8%.
Other lists in this group
Table
5 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.